Immunologic Factors: all 3,292 studies that test it
Page 32 of 33. Open to participants first (386), then studies with results posted, then the rest; newest registration first within each.
- Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00062296Phase 2
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00062114Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCompletedNCT00060684Phase 1
- Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's LymphomaTerminatedNCT00060671Phase 3
- Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's MacroglobulinemiaTerminatedNCT00060294Phase 1
- Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's LymphomaCompletedNCT00059904Phase 2
- Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00059813Phase 2
- Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT00058461Phase 2
- Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00058292Phase 1
- Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNCT00058227Phase 1
- Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.CompletedNCT00057616Phase 3
- Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma PatientsTerminatedNCT00057447Phase 1/2
- Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's LymphomaTerminatedNCT00057343Phase 3
- Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant MelanomaCompletedNCT00055562Phase 2/3
- Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's DiseaseCompletedNCT00055536Phase 2
- Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's DiseaseCompletedNCT00055367Phase 2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerCompletedNCT00053196Phase 2
- Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaCompletedNCT00053157Not applicable
- Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00053131Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell LymphomaCompletedNCT00053092Phase 2
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00053027Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaCompletedNCT00052936Phase 3
- Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell LymphomaCompletedNCT00052923Phase 3
- Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast CancerCompletedNCT00052351Phase 2
- A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple MyelomaCompletedNCT00051116Phase 2
- High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)CompletedNCT00050531Phase 3
- Rituximab to Treat Neuropathy With Anti-MAG AntibodiesCompletedNCT00050245Phase 2
- Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00049413Phase 2
- Phase 1 Study OF CDC-501 in Patients With Solid TumorsCompletedNCT00046735Phase 1
- Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan TreatmentsCompletedNCT00045877Phase 2/3
- Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.CompletedNCT00045864Phase 2
- Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic SyndromeCompletedNCT00044382Phase 2
- CDC-501 Therapy in Relapsed or Refractory Multiple MyelomaCompletedNCT00044018Phase 2
- Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesCompletedNCT00038376Phase 2
- Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic MelanomaStatus unknownNCT00037037Phase 1
- CC-5013 in Treating Patients With Recurrent GliomaCompletedNCT00036894Phase 1
- Anti-CD20 in Systemic Lupus ErythematosusCompletedNCT00036491Phase 1/2
- High-Dose Intravenous Immunoglobulin to Treat Cerebellar DegenerationCompletedNCT00034242Phase 2
- Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusTerminatedNCT00033644Phase 2
- Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00033423Phase 1
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNCT00032799Phase 3
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNCT00032786Phase 3
- Research Study in Patients With Severe Ulcerative ColitisCompletedNCT00032305Phase 2/3
- Research Study of Visilizumab for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00032292Phase 1/2
- Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host DiseaseStatus unknownNCT00032279Phase 2
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00032019Phase 2
- CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyCompletedNCT00031941Phase 1
- Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's LymphomaStatus unknownNCT00031902Phase 1
- Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With MelanomaCompletedNCT00031733Phase 2
- Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell TransplantationCompletedNCT00031642Phase 1/2
- Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisCompletedNCT00030966Phase 3
- Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaStatus unknownNCT00028717Phase 3
- Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00028665Phase 2
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue SarcomaTerminatedNCT00027911Phase 1
- Biological Therapy in Treating Women With Stage IV Breast CancerCompletedNCT00027807Phase 1
- Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell MyocarditisCompletedNCT00027443Not applicable
- Safety and Efficacy of Natalizumab in the Treatment of Multiple SclerosisCompletedNCT00027300Phase 3
- Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00026351Phase 2
- Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00026182Phase 2
- Antibody Production in Immune DisordersTerminatedNCT00023504Phase 4
- Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic LeukemiaTerminatedNCT00022971Phase 1
- Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal CancerStatus unknownNCT00021268Phase 1
- Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00020943Phase 2
- Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00020800Phase 2
- Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerCompletedNCT00020254Phase 2
- Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNCT00019097Phase 2
- Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic SyndromeCompletedNCT00017550Phase 2
- Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00017381Early Phase 1
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
- Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's LymphomaStatus unknownNCT00017290Phase 3
- Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00017121Phase 1
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00016419Phase 2
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
- Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerCompletedNCT00010192Phase 1
- Vaccine Therapy With or Without Sargramostim in Treating Patients With CancerTerminatedNCT00009958Phase 1
- Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerCompletedNCT00008398Phase 3
- Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00007865Phase 2
- Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00007852Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00006747Phase 2
- S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00006708Phase 3
- Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's LymphomaWithdrawnNCT00006669Phase 2
- Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the LungCompletedNCT00006483Phase 2
- Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant MelanomaCompletedNCT00006243Not applicable
- Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT00006240Phase 2
- A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM AutoantibodiesStatus unknownNCT00006072Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaCompletedNCT00006009Phase 1
- Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple MyelomaTerminatedNCT00005987Phase 2
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaStatus unknownNCT00005959Phase 2
- Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes MellitusStatus unknownNCT00005665Phase 2
- Phase II Study of Rituximab in Patients With Immune Thrombocytopenic PurpuraCompletedNCT00005652Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaCompletedNCT00005631Phase 2
- Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerCompletedNCT00005630Phase 1
- Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-AlfaCompletedNCT00005615Phase 1/2
- Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00005610Phase 2
- Rituximab in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00005609Phase 2